GenSight Biologics S.A. (GSGTF)
USD 0.32
(0.0%)
USD 0.32
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.26 Million | 2.76 Million | 5.99 Million | 5.37 Million | 785.74 Thousand | 4.97 Million |
| Cost of Revenue | -1.73 Million | 0.50 | 0.64 | 0.30 | 0.64 | 360.09 Thousand |
| Gross Profit | 3 Million | 2.76 Million | 5.99 Million | 5.37 Million | 785.74 Thousand | 4.61 Million |
| Operating Expenses | 32.66 Million | 33.89 Million | 39.67 Million | 38.47 Million | 38.41 Million | 42.38 Million |
| Selling, General and Administrative Expenses | 7.26 Million | 13.62 Million | 14.04 Million | 11.57 Million | 6.81 Million | 9.5 Million |
| Research and Development Expenses | 19.36 Million | 20.26 Million | 25.63 Million | 26.9 Million | 31.6 Million | 32.87 Million |
| Other Expenses | 4.33 Million | - | - | - | - | - |
| Cost and Expenses | 30.96 Million | 34.99 Million | 40.73 Million | 39.61 Million | 39.52 Million | 42.74 Million |
| Operating Income | -29.69 Million | -32.23 Million | -34.73 Million | -34.23 Million | -38.73 Million | -42.74 Million |
| Interest Expense | 3.15 Million | 3.18 Million | 2.46 Million | 2.1 Million | 456.85 Thousand | 408 Thousand |
| Income Tax Expense | -1.69 Million | -2.36 Million | -2.76 Million | -3.37 Million | -4.72 Million | -4.94 Million |
| Earnings before Tax | -27.91 Million | -31.93 Million | -35.29 Million | -44.99 Million | -39.37 Million | -43.18 Million |
| Net Income | -26.22 Million | -29.56 Million | -32.52 Million | -41.61 Million | -34.64 Million | -38.24 Million |
| Earnings Per Share Basic | -0.54 | -0.64 | -0.72 | -1.18 | -1.22 | -1.56 |
| Earnings Per Share Diluted | -0.54 | -0.64 | -0.72 | -1.18 | -1.22 | -1.56 |
| Weighted Average Shares Outstanding | 48.31 Million | 46.33 Million | 45.15 Million | 35.12 Million | 28.38 Million | 24.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.31 Million | 46.33 Million | 45.15 Million | 35.12 Million | 28.38 Million | 24.46 Million |
| Gross Margin | 2.37 | 1.00 | 1.00 | 1.00 | 1.00 | 0.93 |
| EBIT Margin | -17.15 | -11.26 | -5.62 | -6.16 | -47.89 | -8.51 |
| Profit Margin | -20.69 | -10.70 | -5.42 | -7.74 | -44.10 | -7.68 |
| EBITDA | -21.73 Million | -31.12 Million | -33.67 Million | -31.37 Million | -29.47 Million | -37.49 Million |
| Earnings Before Tax Margin | -23.44 | -11.66 | -5.79 | -6.37 | -49.30 | -8.59 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.16 Million | 3.31 Million | 1.6 Million | 1.69 Million | 2.76 Million | 3.2 Million |
| Cost of Revenue | - | - | - | - | 0.50 | - |
| Gross Profit | 1.16 Million | 3.31 Million | 1.6 Million | 1.69 Million | 2.76 Million | 3.2 Million |
| Operating Expenses | 9.01 Million | 37.96 Million | 16.1 Million | 21.06 Million | 33.89 Million | 16.57 Million |
| Selling, General and Administrative Expenses | 2.92 Million | - | 6.04 Million | 8.39 Million | - | 6.44 Million |
| Research and Development Expenses | 6.09 Million | - | 10.05 Million | 12.67 Million | - | 10.12 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 9.78 Million | 37.96 Million | 16.1 Million | 21.6 Million | 34.99 Million | 17.07 Million |
| Operating Income | -8.61 Million | -34.65 Million | -14.5 Million | -19.91 Million | -32.23 Million | -13.87 Million |
| Interest Expense | 499.14 Thousand | 3.15 Million | - | 1.46 Million | 3.18 Million | 978.83 Thousand |
| Income Tax Expense | -682.3 Thousand | -1.87 Million | -589.39 Thousand | -1.26 Million | -2.36 Million | -1.24 Million |
| Earnings before Tax | -6.94 Million | -30.79 Million | -16.3 Million | -14.31 Million | -31.93 Million | -12.47 Million |
| Net Income | -6.26 Million | -28.91 Million | -15.71 Million | -13.04 Million | -29.56 Million | -11.22 Million |
| Earnings Per Share Basic | -0.13 | - | -0.33 | -0.28 | - | -0.24 |
| Earnings Per Share Diluted | -0.13 | - | -0.33 | -0.28 | - | -0.24 |
| Weighted Average Shares Outstanding | 48.3 Million | 48.3 Million | 47.18 Million | 46.07 Million | 46.33 Million | 46.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.3 Million | 48.3 Million | 47.18 Million | 46.07 Million | 46.33 Million | 46.32 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -4.88 | - | -9.06 | -11.46 | - | -4.17 |
| Profit Margin | -5.38 | -8.73 | -9.82 | -7.72 | -10.70 | -3.50 |
| EBITDA | -5.68 Million | - | -14.5 Million | -19.37 Million | - | -13.36 Million |
| Earnings Before Tax Margin | -7.40 | -10.47 | -9.06 | -11.78 | -11.66 | -4.33 |
PRSMJOHNSN
ENBETRD
BLAL
WNDR
CICN
V03